← Leaderboards
Mehmet M Altintas
University Of Texas Med Br Galveston
$653,108
Attributed
$1,306,215
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $661.9K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,306,215 · 1
By mechanism
R01$1,306,215 · 1
Top collaborators
- Sanja Sever2 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Elisabet Borsheim$6,213,519
- Egle Bytautiene Prewit$2,820,259
- Surendra Sharma$10,214,704
- Madhu Lata S. Chauhan$1,175,978
- Perenlei Enkhbaatar$5,647,075
Others in their field
Other Rising Stars on “Adriamycin Pfs”
- David Gallup · Methodist Hospital Research Institute$1,009,050
- Camille Emilie Adeline Mace · Rush University Medical Center$994,136
- Donghai Wen · Massachusetts General Hospital$755,340
- Gabriel Miguel Cara-Fuentes · Research Inst Nationwide Children'S Hosp$307,302
- Jacob Matthew Wright · Icahn School Of Medicine At Mount Sinai$96,752
Research focus
Adriamycin PfsAdultAffectApplications GrantsBiological MarkersCell Differentiation ProcessCellsCell TypeChronicChronic Kidney FailureCicatrixCombined Modality TherapyComplications Of Diabetes MellitusCyclic GmpCytoskeletonDefined ContributionDesignDiabetes MellitusDiabeticDiabetic NephropathyDisease PhenotypeDisease ProgressionDrug DevelopmentActins